INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
![Foto de INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)](/img/noimage.png)
![Foto de Sahlgrenska University Hospital](/img/noimage_org.png)
Sahlgrenska University Hospital
Gotemburgo, SueciaPublicaciones en colaboración con investigadores/as de Sahlgrenska University Hospital (11)
2024
-
Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial
International Journal of Stroke, Vol. 19, Núm. 1, pp. 120-126
2023
-
Itga8-Cre-mediated deletion of YAP and TAZ impairs bladder contractility with minimal inflammation and chondrogenic differentiation
American Journal of Physiology - Cell Physiology, Vol. 325, Núm. 6, pp. C1485-C1501
2022
-
Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke
Brain, Vol. 145, Núm. 7, pp. 2394-2406
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
Brain, Vol. 144, Núm. 8, pp. 2416-2426
2013
2012
-
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 645-657
2011
-
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Breast Cancer Research, Vol. 13, Núm. 6
-
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Journal of the National Cancer Institute, Vol. 103, Núm. 2, pp. 105-116